113 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 19312046 | KRAS G12C INHIBITORS AND METHODS OF USING THE SAME | KOSTURKO, GEORGE W | 1621 | Non-Final OA | Aug 27, 2025 |
| 19309299 | SOTORASIB DOSING REGIMEN | KOSTURKO, GEORGE W | 1621 | Final Rejection | Aug 25, 2025 |
| 19281019 | SYNTHESIS OF KEY INTERMEDIATE OF KRAS G12C INHIBITOR COMPOUND | SIMMONS, CHRIS E | 1622 | Non-Final OA | Jul 25, 2025 |
| 18857085 | SYSTEMS AND METHODS FOR CONFIGURING A ROBOT TO INTERFACE WITH EQUIPMENT | BUI, NHI QUYNH | 3656 | Non-Final OA | Oct 15, 2024 |
| 18845286 | PACKAGING FOR DRUG DELIVERY DEVICE | TECCO, ANDREW M | 3731 | Non-Final OA | Sep 09, 2024 |
| 18442575 | BINDING AGENTS | WEN, SHARON X | 1641 | Non-Final OA | Feb 15, 2024 |
| 18577109 | TELEPRESENCE DEVICES, SYSTEMS AND METHODS | SCHNURR, JOHN R | 2425 | Non-Final OA | Jan 05, 2024 |
| 18577029 | SYSTEMS AND APPROACHES FOR DRUG PROCESSING USING SINGLE-USE HARDWARE | KUMAR, RAKESH | 3651 | Final Rejection | Jan 05, 2024 |
| 18397218 | 3D PARTICLE IMAGING IN PHARMACEUTICAL CONTAINERS | MCCULLEY, RYAN D | 2611 | Non-Final OA | Dec 27, 2023 |
| 18535068 | FORMULATIONS OF HUMAN ANTI-RANKL ANTIBODIES, AND METHODS OF USING THE SAME | LANDSMAN, ROBERT S | 1647 | Non-Final OA | Dec 11, 2023 |
| 18562107 | SOTORASIB DOSING REGIMEN | CHANDRAKUMAR, NIZAL S | 1625 | Non-Final OA | Nov 17, 2023 |
| 18502780 | NOVEL PRMT5 INHIBITORS | COLEMAN, BRENDA LIBBY | 1624 | Non-Final OA | Nov 06, 2023 |
| 18503009 | DOSING REGIMEN OF KRAS G12C INHIBITOR | AULAKH, CHARANJIT | 1621 | Non-Final OA | Nov 06, 2023 |
| 18558827 | SOTORASIB FORMULATION | GOTFREDSON, GAREN | 1619 | Non-Final OA | Nov 03, 2023 |
| 18288549 | METHOD OF OPTIMIZING A FILLING RECIPE FOR A DRUG CONTAINER | SEIF, DARIUSH | 3731 | Final Rejection | Oct 26, 2023 |
| 18285159 | MAGNETIC DRIVE EXTENSION FOR USE WITH VIRUS INACTIVATION SKID | BHATIA, ANSHU | 1774 | Non-Final OA | Sep 29, 2023 |
| 18284590 | MODULATING PRODUCT QUALITY OF ASYMMETRIC MULTISPECIFIC ANTIBODIES THROUGH THE USE OF TEMPERATURE | AEDER, SEAN E | 1642 | Non-Final OA | Sep 28, 2023 |
| 18367580 | Just-In-Time Learning With Variational Autoencoder For Cell Culture Process Monitoring And/Or Control | HARTMAN JR, RONALD D | 2119 | Non-Final OA | Sep 13, 2023 |
| 18241564 | LEAN PERFUSION CELL CULTURE METHODS | BARRON, SEAN C | 1653 | Non-Final OA | Sep 01, 2023 |
| 18226414 | DRUG DELIVERY DEVICE WITH STERILE FLUID FLOWPATH AND RELATED METHOD OF ASSEMBLY | FLICK, JASON E | 3783 | Non-Final OA | Jul 26, 2023 |
| 18224463 | FORMULATED RECEPTOR POLYPEPTIDES AND RELATED METHODS | MCCOLLUM, ANDREA K | 1674 | Non-Final OA | Jul 20, 2023 |
| 18218782 | DRUG DELIVERY SYSTEM AND METHOD OF USE | HALL, DEANNA K | 3783 | Non-Final OA | Jul 06, 2023 |
| 18270581 | USE OF KRAS G12C INHIBITOR IN TREATING CANCERS | HASTINGS, ALISON AZAR | 1627 | Non-Final OA | Jun 30, 2023 |
| 18269015 | INTELLIGENT MITIGATION OR PREVENTION OF EQUIPMENT PERFORMANCE DEFICIENCIES | ISLAM, MOHAMMAD K | 2857 | Non-Final OA | Jun 22, 2023 |
| 18266689 | DIFFUSION GRADIENT ASSAY FOR ANTI-CD3-CONTAINING MOLECULES | SPENCE, JENNIFER SUZANNE | 1633 | Non-Final OA | Jun 12, 2023 |
| 18255575 | TRICYCLIC CARBOXAMIDE DERIVATIVES AS PRMT5 INHIBITORS | PECKHAM, RICHARD GRANT | 1627 | Non-Final OA | Jun 01, 2023 |
| 18039898 | IMAGE AUGMENTATION TECHNIQUES FOR AUTOMATED VISUAL INSPECTION | THOMPSON, JAMES A | 2615 | Final Rejection | Jun 01, 2023 |
| 18038579 | ENANTIOSELECTIVE ALKENYLATION OF ALDEHYDES | MOORE, SUSANNA | 1624 | Non-Final OA | May 24, 2023 |
| 18038041 | COMPUTER SURROGATE MODEL TO PREDICT THE SINGLE-PHASE MIXING QUALITY IN STEADY STATE MIXING TANKS | RUTTEN, JAMES D | 2121 | Non-Final OA | May 22, 2023 |
| 18316739 | Antibody Constructs for CLDN18.2 and CD3 | MOSELEY II, NELSON B | 1642 | Non-Final OA | May 12, 2023 |
| 18252442 | NOVEL LINKERS OF MULTISPECIFIC ANTIGEN BINDING DOMAINS | SZPERKA, MICHAEL EDWARD | 1641 | Non-Final OA | May 10, 2023 |
| 18035316 | IN-PROCESS VERIFICATION OF CALIBRATION STATUS OF PH PROBES | WALLENHORST, MAUREEN | 1797 | Non-Final OA | May 04, 2023 |
| 18251553 | MATERIALS AND METHODS FOR PROTEIN PROCESSING | BANERJEE, KOYELI | 1658 | Non-Final OA | May 03, 2023 |
| 18035016 | METHODS FOR DECREASING MORTALITY RISK AND IMPROVING HEALTH | ALABI, OYELEYE A | 1797 | Non-Final OA | May 02, 2023 |
| 18035054 | METHODS FOR ADMINISTERING A BCMAXCD3 BINDING MOLECULE | HADDAD, MAHER M | 1641 | Non-Final OA | May 02, 2023 |
| 18034620 | OVEREXPRESSION OF INSULIN-LIKE GROWTH FACTOR RECEPTOR MUTANTS TO MODULATE IGF SUPPLEMENTATION | RAHMAN, MASUDUR | 1633 | Non-Final OA | Apr 28, 2023 |
| 18032765 | DRUG DELIVERY DEVICE ASSEMBLY AND ACCESSORY FOR DRUG DELIVERY DEVICE | RADOMSKI, MARTIN ADAM | 3783 | Non-Final OA | Apr 19, 2023 |
| 18032396 | DRUG DELIVERY DEVICE ASSEMBLY AND ACCESSORY FOR DRUG DELIVERY DEVICE | RODRIGUEZ, CRIS LOIREN | 3783 | Non-Final OA | Apr 18, 2023 |
| 18032014 | DRUG DELIVERY DEVICE ASSEMBLY AND ACCESSORY FOR DRUG DELIVERY DEVICE | STIGELL, THEODORE J | 3783 | Final Rejection | Apr 14, 2023 |
| 18031637 | TITRATION METHODS FOR DETECTING POLYVINYL SULFONATE (PVS) IN BUFFERS | JONES, REESHEDA TAMIKA | 1796 | Non-Final OA | Apr 13, 2023 |
| 18031691 | RELATIVE UNPAIRED GLYCANS IN ANTIBODY PRODUCTION METHODS | ROBINSON, HOPE A | 1652 | Non-Final OA | Apr 13, 2023 |
| 18030685 | PROCESS FOR RACEMIZING AND ISOLATING ATROPISOMERS OF 7-CHLORO-6-FLUORO-1-(2-ISOPROPYL-4-METHYLPYRIDIN-3-YL)PYRIDO[2,3-D]PYRIMIDINE-2,4(1H,3H)-DIONE | RAHMANI, NILOOFAR | 1691 | Non-Final OA | Apr 06, 2023 |
| 18296211 | AMORPHOUS AND CRYSTALLINE FORMS OF MCL-1 ANTAGONISTS | SANCHEZ, JUSTIN CHRISTOPHER | 1622 | Non-Final OA | Apr 05, 2023 |
| 18029995 | POLYVINYL SULFONATE DETECTION AND REMOVAL FROM BIOMOLECULE COMPOSITIONS | HORLICK, KENNETH R | 1681 | Non-Final OA | Apr 03, 2023 |
| 18245004 | METHODS OF DETECTING ISOASPARTIC ACID | XU, XIAOYUN | 1797 | Final Rejection | Mar 13, 2023 |
| 18178086 | CHIMERIC RECEPTORS AND METHODS OF USE THEREOF | STONEBRAKER, ALYSSA RAE | 1642 | Non-Final OA | Mar 03, 2023 |
| 18022685 | PHARMACEUTICAL FORMULATION | HUYNH, PHUONG N | 1641 | Non-Final OA | Feb 22, 2023 |
| 18022245 | SWALLOWABLE DRUG DELIVERY DEVICES | GRAY, PHILLIP A | 3783 | Non-Final OA | Feb 20, 2023 |
| 18042267 | ANTIGEN BINDING PROTEINS WITH NON-CANONICAL DISULFIDE IN FAB REGION | BRISTOL, LYNN ANNE | 1643 | Non-Final OA | Feb 20, 2023 |
| 18018389 | CELL CULTURE MEDIA AND METHODS OF MAKING AND USING THE SAME | VAN BUREN, LAUREN K | 1638 | Non-Final OA | Jan 27, 2023 |
| 18097725 | SYSTEMS AND METHODS FOR DELAYED DRUG DELIVERY | ZAMORY, JUSTIN L | 3783 | Non-Final OA | Jan 17, 2023 |
| 18007560 | RNAI CONSTRUCTS FOR INHIBITING HSD17B13 EXPRESSION AND METHODS OF USE THEREOF | SHIN, DANA H | 1635 | Non-Final OA | Dec 01, 2022 |
| 17928561 | ANTIBODY FORMULATIONS AND USES THEREOF | KIM, YUNSOO | 1641 | Non-Final OA | Nov 29, 2022 |
| 17928320 | TUBING SUPPORT DEVICE AND METHOD OF MANUFACTURE | WEINHOLD, INGRID M | 3632 | Non-Final OA | Nov 29, 2022 |
| 17923347 | Deep Learning Platforms for Automated Visual Inspection | HICKS, AUSTIN JAMES | 2142 | Non-Final OA | Nov 04, 2022 |
| 17774125 | METHODS FOR TREATING LEUKEMIA | BENAVIDES, JENNIFER ANN | 1675 | Non-Final OA | Oct 31, 2022 |
| 17921793 | PHARMACEUTICAL FORMULATION | KAUFMAN, CLAIRE M | 1674 | Non-Final OA | Oct 27, 2022 |
| 17916843 | Synthesis of vinylic alcohol intermediates | HAVLIN, ROBERT H | 1626 | Non-Final OA | Oct 04, 2022 |
| 17913629 | MONOCLONAL ANTIBODIES TO CHEMICALLY-MODIFIED NUCLEIC ACIDS AND USES THEREOF | EMCH, GREGORY S | 1678 | Non-Final OA | Sep 22, 2022 |
| 17910653 | DETERMINATION OF FREE N-TERMINUS OF PEGFILGRASTIM USING AN ACID PROTEASE | MISHRA, DEEPA | 1657 | Non-Final OA | Sep 09, 2022 |
| 17798531 | OMECAMTIV MECARBIL TABLET | GHALI, ISIS A D | 1611 | Final Rejection | Aug 09, 2022 |
| 17797066 | Multivariate Bracketing Approach for Sterile Filter Validation | FUELLING, MICHAEL | 3992 | Non-Final OA | Aug 02, 2022 |
| 17633768 | Anti-Sclerostin Antibody Formulations | REDDIG, PETER J | 1646 | Final Rejection | Jul 25, 2022 |
| 17810142 | STABLE CYCLODEXTRIN FREE CARFILZOMIB FORMULATION | BASQUILL, SEAN M | 1614 | Non-Final OA | Jun 30, 2022 |
| 17786375 | INTERLEUKIN-2 IN COMBINATION WITH TNF RECEPTOR FAMILY MEMBERS FOR THE EXPANSION OF T-REGULATORY CELLS | PATTERSON, SARAH COOPER | 1675 | Final Rejection | Jun 16, 2022 |
| 17778361 | NOVEL MULTISPECIFIC ANTIBODY FORMAT | DONOGHUE, BRITTNEY ERIN | 1675 | Non-Final OA | May 19, 2022 |
| 17745499 | DRUG DELIVERY DEVICE WITH LIVE BUTTON OR USER INTERFACE FIELD | CARPENTER, WILLIAM R | 3783 | Final Rejection | May 16, 2022 |
| 17776622 | HEMATOPOIETIC PRECURSOR CELL PRODUCTION | PRONZATI, GINA | 1633 | Final Rejection | May 13, 2022 |
| 17775386 | Method for Reduced Aggregate Formation in Downstream Processing of Bispecific Antigen-Binding Molecules | SKELDING, ZACHARY S | 1644 | Non-Final OA | May 09, 2022 |
| 17775520 | DOSING REGIMEN FOR ANTI-DLL3 AGENTS | BERHANE, SELAM | 1675 | Final Rejection | May 09, 2022 |
| 17775257 | METHOD OF TREATING OR AMELIORATING CUSHING'S SYNDROME USING BINDING PROTEINS FOR GASTRIC INHIBITORY PEPTIDE RECEPTOR (GIPR) | ALLEN, MARIANNE P | 1647 | Non-Final OA | May 06, 2022 |
| 17775063 | ENGINEERING CHARGE PAIR MUTATIONS FOR PAIRING OF HETERO-IgG MOLECULES | DUFFY, BRADLEY | 1643 | Final Rejection | May 06, 2022 |
| 17773892 | HIGH SALT WASHES DURING CATION EXCHANGE CHROMATOGRAPHY TO REMOVE PRODUCT-RELATED IMPURITIES | SHELTON, SYNPHANE LA'SHAWN | 1652 | Non-Final OA | May 03, 2022 |
| 17773886 | HIGH SALT LOAD CONDITIONING DURING CATION EXCHANGE CHROMATOGRAPHY TO REMOVE PRODUCT-RELATED IMPURITIES | DEBERRY, REGINA M | 1647 | Non-Final OA | May 03, 2022 |
| 17771313 | COMPOSITIONS AND METHODS FOR MINIMIZING PROTEIN LOSS AT LOW PROTEIN CONCENTRATIONS | XIE, XIAOZHEN | 1674 | Final Rejection | Apr 22, 2022 |
| 17770331 | DRUG DELIVERY DEVICE | BOSWORTH, KAMI A | 3783 | Non-Final OA | Apr 20, 2022 |
| 17770320 | SYSTEMS AND COMPONENTS FOR DRUG DELIVERY AND COMPONENTS FOR PREPARATION OF THE SAME | KIM, ERIN ASA | 3781 | Final Rejection | Apr 20, 2022 |
| 17770349 | DRUG DELIVERY SYSTEM AND METHOD OF USE | WITTLIFF, KATERINA ANNA | 3783 | Non-Final OA | Apr 20, 2022 |
| 17769631 | EPOXYAMIDES AS KRAS G12C AND KRAS G12D INHIBITORS AND METHODS OF USING THE SAME | JOHNSON, CHRISTOPHER LINDSAY | 1691 | Final Rejection | Apr 15, 2022 |
| 17763677 | SYSTEMS AND APPROACHES FOR DRUG DELIVERY DEVICE RECONSTITUTION | HAN, SETH | 3781 | Non-Final OA | Mar 25, 2022 |
| 17763824 | METHODS OF PRODUCING ANTIBODY COMPOSITIONS | IVICH, FERNANDO NMN | 1678 | Final Rejection | Mar 25, 2022 |
| 17697632 | BISPECIFIC FC MOLECULES | FAUST, AMBER KATHLEEN | 1643 | Non-Final OA | Mar 17, 2022 |
| 17641736 | Purification Method for Bispecific antigen-binding Polypeptides with Enhanced Protein L Capture Dynamic Binding Capacity | HUYNH, PHUONG N | 1641 | Non-Final OA | Mar 09, 2022 |
| 17690038 | DRUG DELIVERY DEVICE | NICHOLS, CHARLES W | 3783 | Non-Final OA | Mar 09, 2022 |
| 17686766 | MAMMALIAN CELL CULTURE | REGLAS, GEORGIANA C | 1651 | Non-Final OA | Mar 04, 2022 |
| 17640177 | IL-22 ORAL, INTRA-RECTAL, OR OTHER GUT-RELATED COMPOSITIONS AND METHODS OF USE THEREOF | GURLEY, JAMI MICHELLE | 1647 | Non-Final OA | Mar 03, 2022 |
| 17632330 | KIF18A INHIBITORS | MAHLUM, JONATHAN DAVIS | 1625 | Final Rejection | Feb 02, 2022 |
| 17630270 | DRUG DELIVERY DEVICE WITH CONFIGURABLE NEEDLE SHIELD ENGAGEMENT COMPONENTS AND RELATED METHODS | MARRISON, SAMUEL JOSEPH | 3783 | Final Rejection | Jan 26, 2022 |
| 17624824 | MULTISPECIFIC TRANSTHYRETIN IMMUNOGLOBULIN FUSIONS | LEE, JIA-HAI | 1658 | Non-Final OA | Jan 04, 2022 |
| 17620645 | PURIFICATION METHODS FOR CARBOHYDRATE-LINKED OLIGONUCLEOTIDES | GALSTER, SAMUEL LEONARD | 1693 | Final Rejection | Dec 17, 2021 |
| 17616616 | SYSTEMS FOR PERFORMING CELLULAR ANALYSIS AND RELATED DEVICES FOR CONDITIONING ENVIRONMENTS ADJACENT CHIPS IN SUCH SYSTEMS | TURK, NEIL N | 1798 | Non-Final OA | Dec 03, 2021 |
| 17616366 | METHODS OF IDENTIFYING ATTRIBUTES OF THERAPEUTIC PROTEINS | SIMMONS, VALERIE MICHELLE | 1758 | Final Rejection | Dec 03, 2021 |
| 17616580 | BISPECIFIC BINDING CONSTRUCTS | MELCHIOR, JAMES RYLAND | 1644 | Non-Final OA | Dec 03, 2021 |
| 17615520 | RNAI CONSTRUCTS FOR INHIBITING SCAP EXPRESSION AND METHODS OF USE THEREOF | SULLIVAN, STEPHANIE LAUREN | 1635 | Non-Final OA | Nov 30, 2021 |
| 17609363 | MODULATING ANTIBODY EFFECTOR FUNCTIONS | STONEBRAKER, ALYSSA RAE | 1642 | Final Rejection | Nov 05, 2021 |
| 17602148 | DRUG DELIVERY DEVICE WITH SMART GRIP | DIOP, FATIMATA SAHRA | 3783 | Final Rejection | Oct 07, 2021 |
| 17599656 | PREDICTING CELL CULTURE PERFORMANCE IN BIOREACTORS | SCHULTZHAUS, JANNA NICOLE | 1685 | Final Rejection | Sep 29, 2021 |
| 17436696 | GROWTH DIFFERENTIATION FACTOR 15 COMBINATION THERAPY | SZPERKA, MICHAEL EDWARD | 1641 | Final Rejection | Sep 07, 2021 |
| 17436218 | IN VIVO REVERSIBILITY OF HIGH MOLECULAR WEIGHT SPECIES | FRITCHMAN, REBECCA M | 1758 | Non-Final OA | Sep 03, 2021 |
| 17401114 | RNAi CONSTRUCTS AND METHODS FOR INHIBITING MARC1 EXPRESSION | VYAS, KEYUR ANILKUMAR | 1637 | Final Rejection | Aug 12, 2021 |
| 17284551 | AUTOMATIC CALIBRATION AND AUTOMATIC MAINTENANCE OF RAMAN SPECTROSCOPIC MODELS FOR REAL-TIME PREDICTIONS | SCHULTZHAUS, JANNA NICOLE | 1685 | Final Rejection | Apr 12, 2021 |
| 17281896 | METHODS FOR REDUCING AGGREGATION OF BISPECIFIC ANTIBODIES | KIM, YUNSOO | 1641 | Non-Final OA | Mar 31, 2021 |
| 17277533 | PLATFORM ASSEMBLY PROCESS FOR DRUG DELIVERY DEVICE | LALONDE, ALEXANDRA ELIZABETH | 3783 | Final Rejection | Mar 18, 2021 |
| 17264386 | DOSING REGIMEN FOR BCMA-CD3 BISPECIFIC ANTIBODIES | PETRASH, HILARY ANN | 1644 | Final Rejection | Jan 29, 2021 |
| 17264139 | INTERVENTIONAL DOSING SYSTEMS AND METHODS | MARRISON, SAMUEL JOSEPH | 3783 | Final Rejection | Jan 28, 2021 |
| 17262962 | PHARMACEUTICAL FORMULATIONS OF MASKED ANTIBODIES | SWARTWOUT, BRIANNA KENDALL | 1644 | Non-Final OA | Jan 25, 2021 |
| 17036690 | DRUG DELIVERY DEVICE | LALONDE, ALEXANDRA ELIZABETH | 3783 | Final Rejection | Sep 29, 2020 |
| 16964452 | LOW PH PHARMACEUTICAL ANTIBODY FORMULATION | SULLIVAN, DENNIS JOHN | 1642 | Non-Final OA | Jul 23, 2020 |
| 16763515 | METHODS FOR PRODUCING PROTEIN PRODUCTS | HURST, JONATHAN M | 1799 | Final Rejection | May 12, 2020 |
| 16869793 | DOSING REGIMEN FOR ANTI-BCMA AGENTS | BRISTOL, LYNN ANNE | 1643 | Non-Final OA | May 08, 2020 |
| 16348653 | COMBINED THERAPIES FOR ATHEROSCLEROSIS, INCLUDING ATHEROSCLEROTIC CARDIOVASCULAR DISEASE | WEN, SHARON X | 1641 | Final Rejection | May 09, 2019 |
| 14316587 | METHODS FOR TREATING HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA | WEN, SHARON X | 1641 | Final Rejection | Jun 26, 2014 |
| 13931716 | METHODS FOR TREATING OR PREVENTING CHOLESTEROL RELATED DISORDERS | WEN, SHARON X | 1641 | Final Rejection | Jun 28, 2013 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial